基本信息
浏览量:1
职业迁徙
个人简介
The Stokoe lab uses cancer genomics, combined with phenotypic screening, to identify and validate novel oncology drug targets.
Following his postdoc at Onyx Pharmaceuticals, David moved to the University of California at San Francisco to start a lab working on signaling pathways deregulated in cancer. He then joined Genentech to apply some of these findings in a translational setting, and to pursue target identification through cancer genomics and analysis of epigenetic alterations.
研究兴趣
论文共 178 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER RESEARCH COMMUNICATIONSno. 2 (2024): 540-555
crossref(2023)
crossref(2023)
crossref(2023)
Steffan Vartanian,James Lee,Christiaan Klijn,Florian Gnad, Maria Bagniewska,Gabriele Schaefer,Donglu Zhang,Jenille Tan,Sara A. Watson,Liling Liu, Honglin Chen,Yuxin Liang,
crossref(2023)
crossref(2023)
crossref(2023)
Xiaolan Hu,Howard M. Stern,Lin Ge, Carol O'Brien,Lauren Haydu, Cynthia D. Honchell,Peter M. Haverty,Brock A. Peters,Thomas D. Wu,Lukas C. Amler,John Chant,David Stokoe,
crossref(2023)
Steffan Vartanian,James Lee,Christiaan Klijn,Florian Gnad, Maria Bagniewska,Gabriele Schaefer,Donglu Zhang,Jenille Tan,Sara A. Watson,Liling Liu, Honglin Chen,Yuxin Liang,
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn